Industrial And Medical Gases Firms Fined US$1.5bn For Anticompetitive Practices

BMI Core View: Corporate social responsibility (CSR) is an under-appreciated business activity in the pharmaceutical industry. Like all commercial entities, pharmaceutical and medical products firms are fully entitled to focus on the generation of profits and shareholder value. However, recent bad publicity such as product recalls, inappropriate pricing in developing countries and dangerous production processes, means that companies are increasingly accountable to employees, governments, the environment and, most importantly, patients. Firms that do not embrace CSR will lose investors and underperform compared with their

To read the full article, please choose one of the following options: